Accessibility Menu
 
Advanced Biomed logo

Advanced Biomed

(NASDAQ) ADVB

Current Price$6.39
Market Cap$9.01M
Since IPO (2025)-91%
5 YearN/A
1 Year-82%
1 Month+27%

Advanced Biomed Financials at a Glance

Market Cap

$9.01M

Revenue (TTM)

$0.00

Net Income (TTM)

$5.06M

EPS (TTM)

$0.13

P/E Ratio

49.85

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$6.39

Volume

493

Open

$6.39

Previous Close

$6.60

Daily Range

$6.39 - $6.39

52-Week Range

$3.61 - $48.80

ADVB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Advanced Biomed

Industry

Healthcare Equipment and Supplies

Employees

31

CEO

Yi Lu, PhD

Headquarters

New York City, NY 10168, US

ADVB Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

92%

Return on Capital

-18%

Return on Assets

47%

Earnings Yield

2.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.01M

Shares Outstanding

1.36M

Volume

493

Short Interest

0.00%

Avg. Volume

478.18K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$0.00

EBITDA

$0.00

Operating Cash Flow

$181.46K

Capital Expenditure

$985.00

Free Cash Flow

$182.45K

Cash & ST Invst.

$2.90B

Total Debt

$1.26M

Advanced Biomed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$465.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$9.01M

N/A

Market Cap/Employee

$225.15K

N/A

Employees

40

N/A

Net Income

$6.86M

+855.4%

EBITDA

$379.07K

-35.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.58M

+245.8%

Accounts Receivable

$6.18M

+79110.6%

Inventory

$9.07K

+216.2%

Long Term Debt

$1.43K

-97.5%

Short Term Debt

$19.66K

-98.9%

Return on Assets

46.67%

N/A

Return on Invested Capital

-17.95%

N/A

Free Cash Flow

$16.23K

+98.0%

Operating Cash Flow

$15.81K

+98.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHEKCheck-Cap Ltd.
$1.68-11.11%
TRIBTrinity Biotech plc
$0.69-4.10%
GELSGelteq Limited Ordinary Shares
$0.70+0.29%
APMAptorum Group Limited
$0.92+1.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
IMAImageneBio
$5.34+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.66-0.01%
SKYQSky Quarry
$17.75+0.41%

Questions About ADVB

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.